| TUPEB18 | Resistance to second generation integrase inhibitors after two years of a national rollout strategy in Mexico | Poster exhibition | ART resistance |
| TUPEB19 | Doravirine Resistance Patterns Identified through week 192 in the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 clinical trials | Poster exhibition | ART resistance |
| TUPEB20 | HIV viral suppression and drug resistance patterns among adults and children in the era of dolutegravir use: Findings from the national representative cross-sectional survey in Tanzania | Poster exhibition | ART resistance |
| EPC0480 | High dynamic range serologic recency assays can support VL monitoring during ART | E-poster | Cascades of HIV care and treatment |
| EPC0481 | Improving access to HIV prevention and care and treatment for adolescent and youth through community-based service delivery models in Nampula, Mozambique | E-poster | Cascades of HIV care and treatment |
| EPC0482 | Trends in continuity of HIV treatment among children and adolescents living with HIV in fourteen districts in South Africa, 2018 - 2022 | E-poster | Cascades of HIV care and treatment |
| EPC0483 | Mpox cases at a large urban health system in Philadelphia reveal opportunities for strengthening HIV prevention services as part of status-neutral HIV care: results of a retrospective review | E-poster | Cascades of HIV care and treatment |
| EPC0484 | Same day ART initiation, loss to follow-up and viral load suppression among people living with HIV in low- and middle-income countries: a systematic review and meta-analysis | E-poster | Cascades of HIV care and treatment |
| EPC0485 | Effect of the COVID-19 pandemic on HIV service delivery and viral suppression in Northern Nigeria | E-poster | Cascades of HIV care and treatment |
| EPC0486 | Enhanced adherence counselling linkage, completion rates and viral load suppression among people living with HIV in Africa: a systematic review and meta-analysis | E-poster | Cascades of HIV care and treatment |